Cargando…
Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life Support
BACKGROUND: Extracorporeal membrane oxygenation, with an inherent requirement for anticoagulation to avoid circuit thrombosis, is a key element in the treatment of respiratory failure associated with COVID-19. Anticoagulation remains challenging, the standard of care being intravenous continuous adm...
Autores principales: | Wiegele, Marion, Laxar, Daniel, Schaden, Eva, Baierl, Andreas, Maleczek, Mathias, Knöbl, Paul, Hermann, Martina, Hermann, Alexander, Zauner, Christian, Gratz, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309531/ https://www.ncbi.nlm.nih.gov/pubmed/35899208 http://dx.doi.org/10.3389/fmed.2022.879425 |
Ejemplares similares
-
Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
por: Dibiasi, Christoph, et al.
Publicado: (2022) -
Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Gratz, Johannes, et al.
Publicado: (2021) -
Monitoring of Enoxaparin during Hemodialysis Covered by Regional Citrate Anticoagulation in Acute Kidney Injury: A Prospective Cohort Study
por: Wiegele, Marion, et al.
Publicado: (2021) -
Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung transplant patients
por: Gratz, Johannes, et al.
Publicado: (2020) -
Thrombin Generation and Platelet Function in ICU Patients Undergoing CVVHD Using Regional Citrate Anticoagulation
por: Wiegele, Marion, et al.
Publicado: (2021)